A phase IB clinical trial with dekavil (F8-Il10), An immunoregulatory ‘armed antibody’ for the treatment of rheumatoid arthritis, used in combination with methotrexate

M. Galeazzi, L. Bazzichi, G. D. Sebastiani, D. Neri, E. Garcia Gonzalez, N. Ravenni, L. Giovannoni, J. Wilton, M. Bardelli, C. Baldi, E. Selvi, A. Iuliano, G. Minisola, R. Caporali, E. Prisco, S. Bombardieri

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)666
Number of pages1
JournalIsrael Medical Association Journal
Volume16
Issue number10
Publication statusPublished - Oct 1 2014

Keywords

  • Dekavil
  • Methotrexate (MTX)
  • Rheumatoid arthritis (RA)

ASJC Scopus subject areas

  • Medicine(all)

Cite this